Raúl J. Gazmuri
Raúl J. Gazmuri, MD, PhD, FCCM, FAHA
- Founder of Resuscitation Therapeutics, Inc.
- Section Chief of Critical Care Medicine and ICU Director at the Captain James A. Lovell Federal Health Care Center
- Director of the Acute & Critical Care Preclinical and Translational Reseach Lab at the Edward Hines, Jr. VA Hospital
- Former Professor of Medicine, Physiology & Biophysics at Rosalind Franklin University
Dr. Gazmuri is a Critical Care Physician, Section Chief of Critical Care Medicine and ICU Director at the Captain James A. Lovell Federal Health Care Center (FHCC). He obtained his M.D. degree and completed Internal Medicine training in Chile before traveling to the United States in 1986 for a research fellowship at former Finch University of Health Sciences (FUHS) under the mentorship of late Professor Max Harry Weil M.D., Ph.D., regarded as the founder and father of Critical Care Medicine. He spent three years as a full-time research fellow and five additional years as a Critical Care Fellow, Ph.D. student, and junior faculty under Dr. Weil’s mentorship. In 1994, he earned a Ph.D. degree in Physiology & Biophysics, in 1997 he was inducted Fellow of the American College of Critical Care Medicine (FCCM), and in 2024 he was elected Fellow of the American Heart Association (FAHA).
At FHCC, he leads the Section of Critical Care Medicine and pioneered the development of a Rapid Response System based on activation by Single Early Warning Signs (SEWS). He contributes to multicenter clinical trials as local Principal Investigator. In 2010, Rosalind Franklin University (former FUHS), supported the creation of the Resuscitation Institute – for which he served as Director and Principal Investigator, conducting basic science and translational research in various acute life-threatening conditions including cardiac arrest, hemorrhagic shock, traumatic brain injury, and more recently septic shock with special interest in understanding mechanisms at the cell level and developing new treatments for clinical translation. In 2025, he relocated his research lab to the Edward Hines, Jr. VA Hospital, focused on accelerating Acute & Critical Care preclinical and translational research.
Dr. Gazmuri enjoys teaching Medical Students, Residents, and Fellows at the bedside, in his research laboratory, and through an elective course on Acute Care Medicine, emphasizing physiology at the bedside and personalized care. In 2024, he was selected by the Society of Critical Care Medicine as the 2024 recipient of the Asmund S. Laerdal Memorial Lecture Award for his research on Resuscitation and Critical Care Medicine.
Dr. Gazmuri has contributed to the field of Resuscitation and Critical Care Medicine with more than 200 publications and has received, as primary and/or senior author, multiple awards at scientific meetings. He has served as a member of the BLS, ACLS, and the Scientific Subcommittees of the AHA ECC Committee; as a member of ILCOR; as a member of the Resuscitation Science Symposium organizing committee; and occasionally at VHA and NIH Study Sections.
In 2017, he founded Resuscitation Therapeutics, Inc. to translate clinically promising new therapies and strategies for life-threatening medical emergencies in pre-hospital and hospital settings. Currently, working on projects to develop a “New Pharmacology of Resuscitation” and to bring bedside automation for the management of septic shock and other conditions of hemodynamic instability.
